Throughout the COVID-19 pandemic, concern has grown around the increasing reports of substance misuse and substance use disorders. Provisional data, capturing the time period of November 2019–October 2021, indicate a jump in the number of overdose deaths, often occurring with a combination of substances including synthetic opioids as well as stimulants.1
This biweekly, 8-session CoP will include strategies to help health centers address these challenging circumstances. Approaches to treatment and support for these patients in the emergency department, from screening through assessment, and the key considerations to ensure optimal care transitions will be featured. Other topics will include helping staff address stigma, reduce risk of overdose, and support harm reduction strategies, and approaches to person-centered, culturally responsive treatment.
Date: Bi-weekly on Tuesdays starting May 24, 2022 to August 30, 2022
Time: 2:00-3:30 pm EDT
Facilitators: Joe Hyde, MA, LMHC, CAS ; Andrea Coleman, MS (Co-facilitator)
Joe Hyde, MA, LMHC, CAS, is a Senior Technical Expert Lead at JBS International for planning, managing, and directing programs for federal and state agencies and health care and behavioral health providers. Mr. Hyde has more than 35 years of experience in substance use prevention, intervention, and treatment. In collaboration with SAMHSA and American Society of Addiction Medicine, he planned and conducted SAMHSA’s Physician Training for Use of Buprenorphine in multiple states. Mr. Hyde has developed and conducted behavioral health provider trainings on pharmacotherapies for addictive disorders for the Connecticut Department of Mental Health and Addictive Disorders Counselor Training Program and the states of Vermont and Rhode Island. In addition, he served as the conference director and planner for SAMHSA’s 2001 International Conference on Best Practices: Treatment of Opioid Dependence and the state of Vermont’s first Annual Physicians’ Conference on Addiction Medicine. He has worked with clinics and healthcare programs throughout the United States supporting substance use disorder service integration in primary care.
Andrea Coleman, MS, is a Technical Expert Lead and research analyst, with 16 years of experience including training and technical assistance (TTA), evidence-based practices, program and budget management, data collection and analysis in software programs such as ATLAS.ti and MAXQDA, white paper development and report preparation. Previously, she has provided program coordination and management expertise to a national medical education program that helped communities and states plan and implement opioid use disorder (OUD) treatment services, managed the launch of a national website that delivers T/TA and continuing education for health care opioid treatment program professionals implementing electronic health record systems, and undertaken a 5-year, multi-site evaluation of the SAMHSA Targeted Capacity Expansion Program for Substance Abuse Treatment and HIV/AIDS Services and the Rapid HIV Testing component. Ms. Coleman has graduate-level research experience in health information technology with a focus on behavioral health integration with primary care in rural and underserved populations. She holds a Master of Science (MS) in Health Informatics from the University of Illinois at Chicago.
Earn 1.5 continuing education credits for each CoP session, with a maximum of 12 CEs for participation in all eight sessions.